Showing 15 posts of 38 posts found.

US drug spend soars to all-time high in 2014

April 14, 2015
Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing

The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …

Pfizer image

Pfizer posts fourth-quarter revenue decline

January 28, 2015
Sales and Marketing Eliquis, Lipitor, Lyrica (pregablin), Pfizer, Read, Xeljanz, apixaban, financials, pneumococcal vaccine Prevnar, q4, tofacitinib citrate

Pfizer posted a 3% decline in revenue in the last quarter of 2014, the company’s latest financial results show. The …

Pfizer New York HQ

Pfizer revenue drops, but new cancer drugs shine

July 29, 2014
Research and Development, Sales and Marketing Cancer, Inlyta. axitinib, Lipitor, Lyrica, Pfizer, Q2, Sutent, viagra

Pfizer saw a 2% drop in sales for the second quarter but has pointed to the stellar growth of its …


Copycat Lipitor helps toward £1.3bn NHS savings

July 29, 2014
Research and Development, Sales and Marketing ABPI, Lipitor, NHS, Teva, prescribing PPRS, vba

In 2013 generic usage increased to more than three-quarters of all NHS prescriptions according to new data released by the …

Pfizer image

Pfizer faces Australia action

February 14, 2014
Medical Communications, Sales and Marketing Australia, Lipitor, Pfizer, accc

Pfizer has a legal battle on its hands in Australia, where the country’s consumer watchdog has begun proceedings in the …

Pfizer image

Profits drop for Pfizer

January 29, 2014
Sales and Marketing Enbrel, Lipitor, Pfizer, Spiriva, Zoetis, q4

Pfizer’s turnover fell to $54.6 billion in 2013, a 6% drop year-on-year from $54.7 billion in 2012, but the group …

Cancer drugs lift Pfizer in third quarter

October 30, 2013
Sales and Marketing Lipitor, Lyrica, Pfizer, Q3, Xalkori

Pfizer saw a drop in revenue for the third quarter but the future looks bright as new products begin to …

Pfizer image

Lipitor competition holds Pfizer back

July 31, 2013
Sales and Marketing Lipitor, Pfizer, Prevnar, Q2

Pfizer’s revenues in the second quarter of 2013 fell 7% year-on-year, in part due to the loss of patent in …

Pfizer sales shrink 9 per cent

April 30, 2013
Sales and Marketing Ian Read, Lipitor, Pfizer

Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …

Glass particles force recall of Ranbaxy Lipitor

November 27, 2012
Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall

Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …

Pfizer stumbles in third quarter

November 2, 2012
Research and Development, Sales and Marketing Ian Read, Lipitor, Pfizer, Prevnar, Q3

Pfizer has experienced a worse than expected third quarter, due to disappointing sales of paediatric vaccine Prevnar and a surprise …

Lipitor loss continues to hit Pfizer sales

July 31, 2012
Sales and Marketing Enbrel, Lipitor, Pfizer, Prevnar, Q2

Pfizer has posted a loss in revenue for the second quarter as the firm continues to feel the impact of …

Lipitor fallout prompts Pfizer to cut Irish workforce

June 7, 2012
Manufacturing and Production Amgen, Ireland, Lipitor, Pfizer, cuts, patent loss

Falling demand for blockbuster cholesterol drug Lipitor has prompted Pfizer to cut staff levels at two manufacturing facilities in Ireland. …

Plavix loses US patent protection

May 18, 2012
Sales and Marketing BMS, FDA, Lipitor, Pfizer, Plavix, Sanofi

Sanofi and Bristol-Myers Squibb’s blood thinner Plavix has lost its patent protection in the US.  The drug, which made $6.6 …

Latest content